Duragesic 25 mcg/hr (fentanyl transdermal system) CII Pain Patches

and Inc. announced a nationwide recall of all lots of 25 mcg/hr Patches sold in the United States. The product is being recalled because the patches may have a cut along one side of the drug reservoir within the patch which may result in the possible release of gel that may expose patients or caregivers directly to gel on the skin. is a potent Schedule II opioid medication and exposure to the gel may lead to serious adverse events, including respiratory depression and possible overdose, that may be fatal. Patches with a cut edge should not be used. These recalled patches have expiration dates on or before December 2009 and are all manufactured by ALZA Corporation.

Popularity: 53% [?]

Post a Response


Breaking News | Consumer Fraud | Dangers to the Environment | Defective Drugs

Defective Medical Devices | Other Defective Products | Vaccines

© Copyright Defective Products Lawyer 2007. All rights reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Attorney Advertising